Over 10,000 results
10-K/A
2024 FY
ENGN
enGene Holdings Inc.
20 Feb 25
Annual report (amended)
4:38pm
Name | Grant Date | Number Of Securities Underlying Unexercised Options (#) Exercisable | Number Of Securities Underlying Unexercised Options (#) Unexercisable | Option Exercise Price ($)(1) | Option Expiration Date | |||||||||||||
Ronald H.W. Cooper | 7/22/2024 | - | (1) | 1,250,000 | 8.81 | 7/22/2034 | ||||||||||||
Raj S. Pruthi | 4/22/2024 | - | (2) | 125,000 | 14.80 | 4/22/2034 | ||||||||||||
7/24/2024 | - | (3) | 110,000 | 8.65 | 7/24/2034 |
10-K/A
2024 FY
ENGN
enGene Holdings Inc.
20 Feb 25
Annual report (amended)
4:38pm
Name and Address of Beneficial Owner | Number of Shares | Percent of Total Voting Power | ||||||
enGene greater than 5% holders | ||||||||
Forbion Growth (1) | 9,201,434 | 17.2 | % | |||||
Lumira Ventures III, L.P. and affiliates (2) | 4,181,853 | 8.2 | % | |||||
Forbion Capital Fund III Coöperatief U.A. (3) | 3,369,275 | 6.5 | % | |||||
Venrock Healthcare Capital Partners III, L.P. and affiliates (4) | 5,046,414 | 9.9 | % | |||||
Deep Track Biotechnology Master Fund, Ltd. and affiliates (5) | 4,557,575 | 8.9 | % | |||||
Blue Owl Capital Holdings LP (6) | 3,095,069 | 6.1 | % | |||||
Kynam Capital Management and affiliates (7) | 4,994,090 | 9.8 | % | |||||
10-K/A
2024 FY
ENGN
enGene Holdings Inc.
20 Feb 25
Annual report (amended)
4:38pm
Lee G. Giguere | 3/15/2024 | - | (4) | 225,000 | 16.85 | 3/15/2034 | ||||||||||||
Jason D. Hanson | 7/9/2018 | 137,051 | (5) | — | 0.88 | 7/9/2028 | ||||||||||||
7/30/2019 | 30,939 | (5) | — | 0.88 | 7/30/2029 | |||||||||||||
8/20/2021 | 524,544 | (5) | — | 0.88 | 8/20/2031 | |||||||||||||
8/20/2021 | 10,906 | (5) | — | 0.88 | 8/20/2031 | |||||||||||||
7/7/2023 | 512,826 | (5) | — | 4.25 | 7/7/2033 |
10-K/A
2024 FY
ENGN
enGene Holdings Inc.
20 Feb 25
Annual report (amended)
4:38pm
Name(1) | Fees earned or paid in cash(2) | Option Awards(3) | Total |
Jasper Bos(4) | $41,909 | $126,648 | $168,557 |
Gerald Brunk(5) | $71,104 | $126,648 | $197,752 |
Dr. Richard Glickman(6) | $81,838 | $126,648 | $208,486 |
Paul Hastings(7) | $23,918 | $259,993 | $283,911 |
Wouter Joustra(8) | $22,008 | $259,993 | $282,001 |
Lota Zoth(9) | $54,327 | $630,539 | $684,866 |
10-K/A
2024 FY
ENGN
enGene Holdings Inc.
20 Feb 25
Annual report (amended)
4:38pm
Name and Principal Position(1) | Fiscal Year | Salary ($)(2) | Bonus($)(3) | Option Awards ($)(4) | Nonequity Incentive Plan Compensation(5) | All Other Compensation ($)(6) | Total ($) | ||||||||||||||||
Ronald H.W. Cooper | 2024 | 196,951 | - | 7,985,375 | 246,960 | 4,526 | 8,433,812 | ||||||||||||||||
Chief Executive Officer and President | |||||||||||||||||||||||
Raj S. Pruthi, MD, MHA, FACS | 2024 | 253,483 | - | 2,005,951 | 200,320 | 6,305 | 2,466,059 | ||||||||||||||||
Chief Medical Officer | |||||||||||||||||||||||
Lee G. Giguere | 2024 | 312,735 | 137,150 | 2,698,001 | 147,862 | 7,701 | 3,303,449 | ||||||||||||||||
Chief Legal Officer & Secretary | |||||||||||||||||||||||
Jason D. Hanson | 2024 | 427,283 | - | - | - | 571,946 | 999,299 | ||||||||||||||||
Former Chief Executive Officer | 2023 | 442,337 | - | 1,536,357 | 204,340 | 9,900 | 2,192,934 |
10-K/A
0whhsdz
20 Feb 25
Annual report (amended)
4:38pm
10-K/A
52amdwjqh
20 Feb 25
Annual report (amended)
4:38pm